Treatment of cancer under the impression of the COVID-19 pandemic is associated with completely new challenges. Based on several underlying factor cancer patients per se harbor an increased risk for dismal outcome of COVID. Age, malnutrition, pre-existing lung disorders and immune suppression comprise the most notable factors to be taken into account in cancer patients. As radiotherapy is one of the major pillars in oncology, there is an urgent need for recommendations on how to deal with various facets of COVID-19 in the framework of radiation oncology. The article by S. Combs et al represents the result of a consensus discussion between representatives from five large University Hospitals in Germany, Austria and Switzerland.
Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. It publishes findings in molecular and cellular radiation biology, radiation physics, radiation technology, and clinical oncology.
The field of radiation oncology covers the integration of radiation therapy into multimodal treatment approaches. Radiation Oncology provides an open access forum for researchers and clinicians involved in the management and treatment of cancer patients, bringing together the latest research and advances in the field. Advances in treatment technology, as well as improved understanding of the underlying biological resistance mechanisms, will further strengthen the role of radiation oncology.
Radiation Oncology – dedicated to the latest advancements in MR-guided radiotherapy – presents a collection of review and research articles highlighting the status of the field. The contributions discuss recent challenges, and present potential future directions.
To be accepted in the RANZCR training program, you must:
Have MBBS or equivalent medical qualifications as recognised by the registering authority of the country in which the RANZCR training program is conducted and the Board of the College
Be registered as a medical practitioner by the registered authority recognised by the Board of the College in the state or country where you are training (Australia, New Zealand or Singapore)
Have completed at least two full years in an approved hospital as an intern or resident.
As well as meeting the prerequisites, you must also be able to demonstrate:
Dedication to pursuing a career in radiation oncology
Good interpersonal and professional communication skills
A high standard of academic performance.
Other desirable qualities are:
Radiotherapy training in India encompasses the treatment of solid tumors in terms of Chemotherapy, radiation therapy, and palliative care in most states. Postgraduate MD degree is awarded after 3 years of post-MBBS in-service comprehensive training and a final university level exam. MD Radiation oncology practitioners are the most proficient oncologists in India delivering radiotherapy and chemotherapy. The first Radiotherapy department of Asia was set up in 1910 at Calcutta Medical College in the state of West Bengal and is still a leading oncology training center of India.
The article submission is accepted through an online submission system as well as email at firstname.lastname@example.org or Submit online